Crescent Capital Group is a global alternative investment manager singularly focused on corporate credit, investing in debt securities across the capital structure in both private and tradeable markets. The firm has approximately $50 billion in assets under management and has been investing in below-investment-grade credit markets for over 30 years.
Average disclosed round size is $336.7M (across 3 rounds with reported amounts).
Portfolio
8
Fund Size
$10.8B
Top Stage
Unknown
Last 12 Mo
1
Team
Albert Lee
Managing Director
Alexander Chi
Managing Director
Becky Chuen
Managing Director
Brian Ferguson
Managing Director
Christopher Krukowski
Managing Director
Christopher Wang
Managing Director
Clayton Bruce
Managing Director
Doran Chernichen
Managing Director
Elena Cosic
Managing Director
Portfolio Breakdown
Stage Distribution
Sector Distribution
Investment Activity
Portfolio
| Company | Round | Amount | Date |
|---|---|---|---|
 Exeliom Biosciences | Series A | — | Oct 2025 |
 Our Next Energy | Unknown | — | Mar 2025 |
| Exeliom Biosciences | Series A | — | Jul 2023 |
| EExeliom Biosciences | Series A | — | Jul 2023 |
 PCF Insurance Services | Growth | — | Feb 2023 |
 Trucordia Insurance Services LLC | Unknown | $500M | Jan 2023 |
| PPCF Insurance | Unknown | $500M | Jan 2023 |
 Modern Democracy | Unknown | — | — |
| NNorthLadder | Series B | $10M | — |
Top Co-Investors
Last updated: 20 October 2026